Clinical trial
Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina
NCT00225342
Study timeline
Registry last updated2006-09-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Angina Pectorisunresolved
Diabetes Mellitus, Type 2unresolved
Interventions
RosiglitazoneDRUG · verified · RxNorm: rosiglitazone
Sponsors & collaborators
University of Glasgowlead sponsor
GlaxoSmithKlinecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00225342 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.